Fingerprint
Dive into the research topics of 'Inhibition of axl and vegf‐a has improved therapeutic efficacy in uterine serous cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Inhibition of axl and vegf‐a has improved therapeutic efficacy in uterine serous cancer
Michael D. Toboni, Elena Lomonosova, Shaina F. Bruce, Jo’An I. Tankou, Mary M. Mullen, Angela Schab, Alyssa Oplt, Hollie Noia, Danny Wilke, Lindsay M. Kuroki, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, Dineo Khabele, David G. Mutch, Katherine C. Fuh
- Division of Gynecologic Oncology
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- Institute for Public Health
- Department of Obstetrics & Gynecology
- Washington University School of Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- DBBS - Biochemistry, Biophysics, and Structural Biology
Research output: Contribution to journal › Article › peer-review